Industry reports
Editor highlights

Biopharmaceutical Industry in the United States: Market Research Reports, Statistics and Analysis

You might be interested in: biosimilar, protein, bioprocessing, more »

» View Public Reports

About 400 reports

Biopharmaceutical Sector in The United States and Canada

  • Industry report
  • May 2013
  • 22 pages

... Electrophoresis (sds- page) (10%) and transferred to pvdf membrane. To detect the recombinant protein the membrane was incubated with primary mouse anti-c-myc monoclonal antibody (genscript, a00864, piscataway ...

Biopharmaceutical in The United Kingdom and The United States : Innovation and Technology Trends

  • Industry report
  • November 2012
  • 5 pages
  • by Research Paper

... Of conservatism. 30 bioprocess international 12(1) january 2014 electronic preprint focused on whether advancements in the industry such as higher titers, single-use technologies, and membrane ...

Biopharmaceutical in The United States and Canada : Innovation and Technology Trends

  • Industry report
  • August 2012
  • 26 pages

... Information, future events or otherwise. Nothing herein should be construed as an offering of securities of the company in any jurisdictions. 3 Company overview focus vaccines / biosimilars ...

Biopharmaceutical in India and The United States : Industry Overview and Key Players

  • Industry report
  • June 2012
  • 19 pages

... Such as microbial fermentation or mammalian cell culture. Ge plants, acting as bioreactors, can efficiently produce recombinant proteins in larger quantities than those produced using mammalian cell systems (3 ...

Biopharmaceutical in Germany and The United States : Innovation and Technology Trends

  • Industry report
  • June 2012
  • 8 pages

... Fundamental requirements, such as conformance to gmps and compendial quality standards (e.G. Nonproprietary naming/identity; strength, quality, purity) the new biosimilars 351(k) marketing pathway has some ...

Biopharmaceutical Sector Statistics in The United States, Switzerland and The Czech Republic

  • Industry report
  • April 2012
  • 39 pages

... Viral vector gene therapy, viral vaccine applications) slide 27 strain development and cell banking fermentation and recovery development purification and refold development analytical development ...

U.S. Biopharmaceutical Business Brief

  • Industry report
  • March 2012
  • 8 pages

... Of protein. To accomplish the initial stages of evaluation of this protein as a human-use vaccine against malaria, we immunized rabbits and mice with lsa-nrc in montanide isa 720. New zealand white rabbits ...

Biopharmaceutical Sector Analysis in The United States

  • Industry report
  • March 2012
  • 255 pages
  • by Research Paper

... J. Van den hondel, and p. J. Punt. 2001. Production of tissue plasminogen activator (t-pa) in aspergillus niger. Biotechnology and bioengineering 76:164-174. Withers, j. M., R. J. Swift, m. G ...

Biopharmaceutical Sector in The United States

  • Industry report
  • February 2012
  • 7 pages

... Deglycosylated igg has been reported in monoclonal antibody products such as tocilizumab and plantibodies of herceptin. Quantitation was achieved by separating the glycopeptide either by ce [14] or hplc ...

Search in Biopharmaceutical Industry

» Purchase Premium Reports (From $ 125 - $ 5 000)

About 300 reports
Commercial Potential of the Forthcoming US Biosimilars Market 

Commercial Potential of the Forthcoming US Biosimilars Market 

  • $ 5 000
  • Industry report
  • February 2014
  • by Frost & Sullivan

An Addendum to “Specialty Physicians Discuss their Opinions of the United States Biosimilars Market” Executive Summary •The arrival of biosimilars, or highly similar copies of biopharmaceutical products, ...

Alcohol And Starch/sugar Enzyme Market By Type (carbohy ...

March 2014 $ 4 650

Vaccines, Skin Replacement Products And Biologicals Man ...

February 2014 $ 1 995

Global Antibody Drug Conjugate Market Outlook 2018

March 2014 $ 1 200

Competitor Analysis: Cancer Vaccines

March 2014 $ 1 056

Physician Views - Are Physicians Getting The Biosimilar ...

April 2014 $ 731

Freedonia Focus On Enzymes: United States

January 2014 $ 600

Competitor Analysis: Cd20 Antibodies - Rituximab Biosim ...

February 2014 $ 396

Verenium Corporation (symbol:vrnm) Swot Analysis, Strat ...

April 2014 $ 300

Biomedical Enterprises, Inc. Swot Analysis, Strategy, R ...

February 2014 $ 300

» Read our Company Profiles

1 Companies

Repligen Corp.

United States

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.